Literature DB >> 5423891

Recurrent hepatitis in patients receiving multiple halothane anesthetics for radium treatment of carcinoma of the cervix uteri.

M Hughes, L W Powell.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5423891

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  10 in total

Review 1.  Halothane and liver damage.

Authors:  D Rosenak; A Halevy; R Orda
Journal:  Postgrad Med J       Date:  1989-03       Impact factor: 2.401

2.  A comparison of the effects of halothane and other anaesthetic agents on hepato-cellular function in patients submitted to elective operations.

Authors:  B Kalow; E Rogoman; F H Sims
Journal:  Can Anaesth Soc J       Date:  1976-01

3.  Halothane hepatitis: fact or fallacy.

Authors:  B R Simpson; L Strunin; B Walton
Journal:  Bull N Y Acad Med       Date:  1973-08

Review 4.  The halothane dilemma: a case for the defence.

Authors:  B R Simpson; L Strunin; B Walton
Journal:  Br Med J       Date:  1971-10-09

Review 5.  Halothane hepatitis.

Authors:  S Sherlock
Journal:  Gut       Date:  1971-04       Impact factor: 23.059

6.  A morphologic study of unexplained hepatitis following halothane anesthesia.

Authors:  E J Wills; B Walton
Journal:  Am J Pathol       Date:  1978-04       Impact factor: 4.307

7.  Halothane hepatitis--a preventable disease?

Authors:  P Sharpstone; D R Medley; R Williams
Journal:  Br Med J       Date:  1971-02-20

8.  Halothane hepatitis.

Authors:  A H Qizilbash
Journal:  Can Med Assoc J       Date:  1973-01-20       Impact factor: 8.262

9.  Jaundice after multiple halothane anaesthetics administered during the treatment of carcinoma of the uterus.

Authors:  P Davis; C D Holdsworth
Journal:  Gut       Date:  1973-07       Impact factor: 23.059

10.  Halothane macrophage migration inhibtiion factor test in halothane-associated hepatitis.

Authors:  C D Price; A R Gibbs; W J Williams
Journal:  J Clin Pathol       Date:  1977-04       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.